Strata Skin Sciences
SSKN
SSKN was delisted on the 18th of February, 2026.
28 hedge funds and large institutions have $26.4M invested in Strata Skin Sciences in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
19% more capital invested
Capital invested by funds: $22.1M → $26.4M (+$4.3M)
12% more funds holding
Funds holding: 25 → 28 (+3)
0.28% more ownership
Funds ownership: 2.82% → 3.1% (+0.28%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$2.11M |
| 2 |
Renaissance Technologies
New York
|
+$398K |
| 3 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$278K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$146K |
| 5 |
VF
Virtu Financial
New York
|
+$41.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$380K |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$77.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$71K |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$40K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$26K |
SSKN Hedge Fund Activity: Q1 2019 in Review
28 of the 4,632 institutional investors tracked by Wall St. Rank reported a position in Strata Skin Sciences (SSKN) for Q1 2019, worth a combined $26.4M — up 19% from $22.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SSKN positions and 4 closed out — a net gain of 3 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was Broadfin Capital, adding an estimated $2.11M. The largest seller was Nantahala Capital Management, cutting an estimated $380K.
- 28 institutional investors held Strata Skin Sciences (SSKN) as of Q1 2019, up from 25 in Q4 2018.
- Funds reported $26.4M of Strata Skin Sciences stock for Q1 2019, up 19% quarter-over-quarter.
- 7 funds opened new Strata Skin Sciences positions in Q1 2019 and 4 closed out, a net change of +3 holders.
- The largest Strata Skin Sciences buyer in Q1 2019 was Broadfin Capital, an estimated $2.11M added.
- The largest Strata Skin Sciences seller in Q1 2019 was Nantahala Capital Management, an estimated $380K sold.
Based on aggregated 13F filings for Q1 2019.